Higher activity by opaque endometriotic lesions than nonopaque lesions
- PMID: 15005786
- DOI: 10.1111/j.0001-6349.2004.00229.x
Higher activity by opaque endometriotic lesions than nonopaque lesions
Abstract
Background: Higher activity by early endometriosis than advanced endometriosis has been reported. However, the pattern of activity in individual colored endometriotic lesions in pelvic cavity is unknown. We investigated the variation in activity of the different colored morphologic lesions as proposed by the current revised American Society of Reproductive Medicine (ASRM) classification in women with endometriosis.
Methods: Peritoneal fluid (PF) and biopsies were collected during laparoscopy from 45 infertile women with pelvic endometriosis and 15 women without endometriosis. PF concentrations of hepatocyte growth factor (HGF), vascular endothelial growth factor (VEGF), interleukin-6 (IL-6) and monocyte chemotactic protein-1 (MCP-1) were measured by enzyme-linked immunosorbent assay (ELISA). The immunohistochemical staining of HGF and proliferating cell nuclear antigen (PCNA) in opaque and nonopaque endometriotic lesions was examined using respective antibodies, and a computer-analyzed modified quantitative-histogram score (Q-H score) was used to quantify the immunoreaction.
Results: Opaque red lesions were defined as nontransparent lesions, including polypoid excrescence, blood bleb or ecchymosis, and nonopaque lesions were defined as translucent or transparent lesions, including vesicular bleb or clear papule. The women with endometriosis containing dominant opaque red lesions showed significantly higher PF concentrations of HGF, VEGF, IL-6 or MCP-1 than those with either nonopaque lesions or black lesions or control women. There was no difference in any of these cytokine or chemokine levels between women harboring nonopaque lesions and black lesions. Interestingly, PF concentrations of all these markers were significantly reduced in women containing true black lesions and true white lesions after excluding the presence of coexisting red spot from dominant black or white lesions. In a parallel fashion, the immunoexpressions of HGF and PCNA in intact tissue as shown by the Q-H score were significantly stronger in the opaque red lesions than in the nonopaque lesions or black lesions.
Conclusions: Opaque red lesions display a higher activity than with nonopaque red lesions in both PF and intact tissue. This indicates different histogenesis in their generation in the pelvic cavity.
Similar articles
-
Immunoexpression of hepatocyte growth factor and c-Met receptor in the eutopic endometrium predicts the activity of ectopic endometrium.Fertil Steril. 2003 Jan;79(1):173-81. doi: 10.1016/s0015-0282(02)04535-1. Fertil Steril. 2003. PMID: 12524084
-
Peritoneal fluid and serum levels of hepatocyte growth factor may predict the activity of endometriosis.Acta Obstet Gynecol Scand. 2006;85(4):458-66. doi: 10.1080/00016340500432556. Acta Obstet Gynecol Scand. 2006. PMID: 16612709 Clinical Trial.
-
Association of interleukin-6 and estradiol with hepatocyte growth factor in peritoneal fluid of women with endometriosis.Acta Obstet Gynecol Scand. 2002 Aug;81(8):764-71. doi: 10.1034/j.1600-0412.2002.810814.x. Acta Obstet Gynecol Scand. 2002. PMID: 12174163
-
Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities.Fertil Steril. 1997 Oct;68(4):585-96. doi: 10.1016/s0015-0282(97)00191-x. Fertil Steril. 1997. PMID: 9341595 Review.
-
IL-17: an important pathogenic factor in endometriosis.Int J Med Sci. 2022 Apr 11;19(4):769-778. doi: 10.7150/ijms.71972. eCollection 2022. Int J Med Sci. 2022. PMID: 35582411 Free PMC article. Review.
Cited by
-
VASCULAR ENDOTHELIAL GROWTH FACTOR SERUM LEVELS IN WOMEN WITH ADVANCED ENDOMETRIOSIS.Acta Endocrinol (Buchar). 2016 Jan-Mar;12(1):7-13. doi: 10.4183/aeb.2016.7. Acta Endocrinol (Buchar). 2016. PMID: 31258793 Free PMC article.
-
Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target.Front Immunol. 2021 Jan 11;11:599117. doi: 10.3389/fimmu.2020.599117. eCollection 2020. Front Immunol. 2021. PMID: 33505394 Free PMC article. Review.
-
Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review.J Clin Med. 2021 Mar 5;10(5):1085. doi: 10.3390/jcm10051085. J Clin Med. 2021. PMID: 33807739 Free PMC article. Review.
-
Pro-inflammatory cytokines for evaluation of inflammatory status in endometriosis.Cent Eur J Immunol. 2015;40(1):96-102. doi: 10.5114/ceji.2015.50840. Epub 2015 Apr 22. Cent Eur J Immunol. 2015. PMID: 26155190 Free PMC article.
-
Intraoperative detection of subtle endometriosis: a novel paradigm for detection and treatment of pelvic pain associated with the loss of peritoneal integrity.J Vis Exp. 2012 Dec 21;(70):4313. doi: 10.3791/4313. J Vis Exp. 2012. PMID: 23288271 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous